LON:CIZ Cizzle Biotechnology (CIZ) Share Price, News & Analysis GBX 3.63 +0.43 (+13.44%) As of 12:33 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartHoldingsBuy This Stock About Cizzle Biotechnology (LON:CIZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cizzle Biotechnology alerts:Sign Up Key Stats Today's Range 3▼ 3.6350-Day Range 1.42▼ 3.5052-Week Range 1.20▼ 3.90Volume1.75 million shsAverage Volume1.25 million shsMarket Capitalization£14.39 millionAssets Under Management£48.98 millionDividend Yield3.54%Net Expense Ratio0.46%Aggregate RatingN/A ETF Overview Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. Read More Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.58%0.57%0.45%0.53%Other Expenses0.25%0.27%0.55%0.25%0.55%Total Expense0.66%0.65%0.76%0.54%0.73%Fee Waiver-0.20%-0.23%-0.64%-0.20%-0.61%Net Expense0.46%0.62%0.63%0.47%0.60% Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CIZ ETF News HeadlinesCizzle says process of preparing submission for CLIA near completionFebruary 23, 2026 | lse.co.ukCizzle Biotechnology Advances U.S. Rollout of Lung Cancer TestSeptember 29, 2025 | msn.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 15 at 1:00 AM | Banyan Hill Publishing (Ad)Cizzle Bio CEO Bill Behnke Named by CXO Outlook® as "Most Inspiring Business Leader 2025" for Advancing Breakthrough Early Cancer Detection Blood TestsSeptember 3, 2025 | finance.yahoo.comSan Antonio biotech company creates blood test for early cancer detectionAugust 11, 2025 | msn.comCizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood Test for Lung CancerJuly 9, 2025 | finance.yahoo.comSee More Headlines CIZ ETF - Frequently Asked Questions How have CIZ shares performed this year? Cizzle Biotechnology's stock was trading at GBX 1.43 at the beginning of 2026. Since then, CIZ stock has increased by 153.8% and is now trading at GBX 3.63. How were Cizzle Biotechnology's earnings last quarter? Cizzle Biotechnology Holdings Plc (LON:CIZ) released its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.17) earnings per share for the quarter. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Cizzle Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Baidu (BIDU). Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com Phone44-20-3934-6630Fund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9.24 thousand Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares396,392,000Beta0.07 Creation Unit50,000 Creation Fee$4,500.00 Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 4 CIZ HoldingsFederated Treasury Obligations FundHolding Weight: 100.00%China Common Rich RenHolding Weight: 0.00%Constellation Software InHolding Weight: 0.00%EVRAZ PLCHolding Weight: 0.00%Full Holdings DetailsCIZ Sector ExposureCIZ Industry Exposure This page (LON:CIZ) was last updated on 5/15/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cizzle Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
